The novel treatment of tirzepatide peptide represents a major development in the handling of type 2 diabetes. Different to existing drugs, tirzepatide impacts multiple pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide264063.is-blog.com/48981539/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment